Clinical Trials Logo

Clinical Trial Summary

The prompt treatment of pain due to minor trauma is often an unmet need in both Emergency Room Department and Ambulance Rescue. Most of the available drugs are intravenously administered and such route of administration may account for delay in the pain relief onset.

Methoxyflurane is an halogenated anesthetic, self-administered by the patient at sub-anesthetic dose through an easy to handle inhaler (Penthrox®). The efficacy and safety of Penthrox® in the treatment of acute traumatic pain will be investigated in an out-of-hospital and in hospital emergency medical care setting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03585374
Study type Interventional
Source Mundipharma Pharmaceuticals srl
Contact
Status Completed
Phase Phase 3
Start date February 8, 2018
Completion date February 22, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02866071 - Intranasal Ketamine as an Adjunct to Fentanyl for the Prehospital Treatment of Acute Traumatic Pain Phase 3
Completed NCT04618497 - A Pilot Study on the Use of Methoxyflurane (Penthrox®) for Pain Control in the Emergency Department Phase 3
Completed NCT01731184 - Morphine-Midazolam in Pre-hospital Traumatic Patients With Severe Acute Pain Phase 3
Not yet recruiting NCT03511833 - Comparison of Treatment by IN Ketamine to IV Morphine in Acute Pain Phase 3